Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Can microbial bile acid deconjugation and low biliary phospholipid availability reduce mixed micelle formation and impair triglyceride handling?

Microbial bile acid deconjugation and low biliary phospholipid availability can reduce mixed micelle formation and impair triglyceride handling.

PlausibleJuly 31, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Microbial bile acid deconjugation, low biliary phospholipid availability, and mucosal inflammation can interact to reduce mixed micelle formation and create a self-reinforcing pattern of impaired triglyceride handling.

laying out figure…
0 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a mechanism in which bacterial bile acid deconjugation and depleted biliary phospholipids work together to limit mixed micelle assembly. The conclusion frames this as a cause of triglyceride malabsorption that can also promote mucosal irritation and inflammation, creating a reinforcing cycle.

Verified conclusion

Efficient lipid absorption relies on the seamless assembly of mixed micelles to solubilize dietary fats. When this process is disrupted, it triggers a cascade of mucosal irritation and malabsorption.

Mechanistic pathways of micellar disruption

  • Bile Acid Deconjugation: Bacterial species expressing bile salt hydrolase (BSH) deconjugate bile salts into free bile acids. These unconjugated forms have altered amphipathic properties, reducing their detergent effectiveness and directly preventing mixed micelle assembly.
  • Phospholipid Depletion: Insufficient biliary phosphatidylcholine depletes the essential structural components required to emulsify and solubilize lipids within the intestinal lumen.
  • Impaired Micelle Assembly: The combination of deconjugated bile acids and phospholipid deficiency prevents mixed micelle formation, directly causing triglyceride malabsorption.

Pathophysiological feedback loops

  • Mucosal Damage: Free, deconjugated bile acids act as direct mucosal irritants that damage enterocytes and alter host immune gene expression, driving mucosal inflammation.
  • Enterocyte Dysfunction: Inflammation degrades enterocyte membrane function and barrier integrity, compromising the cellular machinery needed for triglyceride uptake.
  • Self-Reinforcing Loop: Unabsorbed luminal lipids accumulate and undergo bacterial fermentation or hydroxylation. This increases mucosal irritation and inflammation, further impairing the gut's lipid-handling capacity.

Bottom line

  • Bacterial bile acid deconjugation and depleted biliary phospholipids cooperatively disrupt mixed micelle assembly. This drives triglyceride malabsorption and generates cytotoxic free bile acids, establishing a self-reinforcing cycle of mucosal inflammation and chronic lipid malabsorption.

References

  1. Small Intestinal Bacterial Overgrowth - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  2. The Malabsorption Syndrome and Its Causes and ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease — tandfonline.com ↗
  4. A9 BACTERIAL BILE SALT HYDROLASE GENE ABUNDANCE IS ASSOCIATED WITH RORC GENE EXPRESSION IN INTESTINAL MUCOSA OF INFLAMMATORY DISEASE PATIENTS — academic.oup.com ↗
  5. Pancreatic and mucosal enzymes in choline phospholipid digestion | American Journal of Physiology-Gastrointestinal and Liver Physiology | American Physiological Society — journals.physiology.org ↗
  6. Intestinal lipid absorption - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  7. Peer Review File Gut microbiota restricts intestinal lipid uptake ... — media.springernature.com ↗
  8. The Impact of Small Intestinal Bacterial Overgrowth on ... — med.virginia.edu ↗
  9. Effect of Bacteroides melaninogenicus culture supernatant ... — pubmed.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→